Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)

Lawrence W. Elmer, Jorge L. Juncos, Carlos Singer, Daniel D. Truong, Susan R. Criswell, Sotirios Parashos, Larissa Felt, Reed Johnson, Rajiv Patni

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum to: Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease (CNS Drugs, (2018), 32, 4, (387-398), 10.1007/s40263-018-0498-4)'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science